Qube Research & Technologies »

Esperion Therapeutics shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2023-09-30 $31k 32k 0.98
2023-06-30 $172k 124k 1.39
2023-03-31 $72k 45k 1.59

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Visa Com Cl A Call Option (V)
Meta Platforms Cl A Call Option (META)
Adobe Systems Incorporated Call Option (ADBE)
McDonald's Corporation Call Option (MCD)
NVIDIA Corporation Call Option (NVDA)
salesforce Call Option (CRM)
Netflix Call Option (NFLX)
Johnson & Johnson Put Option (JNJ)
Cisco Systems Put Option (CSCO)
Bank of America Corporation Call Option (BAC)

View all positions for Qube Research & Technologies

Top funds holding Esperion Therapeutics

Daniel D. Thurber
Vanguard Group
Bellevue Group
Meditor
Millennium Management
Two Sigma Investments
Two Sigma Advisers
Jpmorgan Chase & Co
Tang Capital Management
D. E. Shaw & Co
Walleye Trading
GSA Capital Partners
Schonfeld Strategic Advisors
Jacobs Levy Equity Management
Goldman Sachs Group

View all funds holding Esperion Therapeutics